MiniMed的IPO启动, 提供2800万股, 价值25-28美元, MiniMed's IPO begins, offering 28M shares at $25–$28, as Medtronic spins off its diabetes unit.

作为Medtronic计划的一部分, MiniMed已开始其IPO道路展, 提供2800万股, 每股2500美元至28.00美元, 承保人可以选择再购买420万股。 MiniMed has begun its IPO roadshow as part of Medtronic’s plan to spin off its diabetes business, offering 28 million shares at $25.00 to $28.00 each with an option for underwriters to buy 4.2 million more. 该公司准备根据MED将Nasdaq列入MMED名单,在IPO之后将保留大约90%的所有权,其收益将用于偿还Medtronic的债务和支持业务。 The company, set to list on Nasdaq under MMED, will retain about 90% ownership post-IPO, with proceeds used to repay Medtronic debt and support operations. 这一举动标志着师团向独立过渡的关键一步。 The move marks a key step in the division’s transition to independence.